^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

orantinib (TSU-68)

i
Associations
Trials
Company:
Otsuka, Pfizer
Drug class:
c-KIT inhibitor, FGFR inhibitor, PDGFR inhibitor, VEGFR-2 inhibitor
Related drugs:
Associations
Trials